Startup Science Corp will begin selling a retina chip in Europe that restores some sight to people with a form of age-related blindness, a milestone for the company that aspires to eventually bring brain implants to the market.
Ike Swetlitz is a Health Reporter at various esteemed publications including Financial Post and Bloomberg Law. He focuses on themes such as medicine and healthcare, pharmaceuticals, and healthcare technology, exploring topics like pharmaceutical manufacturing, consumer health, and public health. Ike's work has been featured in notable outlets like TIME, Fortune, and The Boston Globe.